Neurocrine Biosciences | Creditori Commerciali



Trade Creditors Cambiamento Data
AbbVie 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
ALKERMES USD 59.84M 14.21M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Cytokinetics USD 13.94M 6.43M 2025-03
Dynavax Technologies USD 4.33M 4.73M 2025-03
Exelixis USD 42.84M 4.65M 2025-04
Gilead Sciences USD 833M 70M 2024-12
Halozyme Therapeutics USD 20.07M 9.82M 2025-03
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Pfizer USD 5.24B 393M 2025-03
Prothena USD 7.77M 2.56M 2024-12
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Repligen USD 26.94M 5.2M 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Teva Pharmaceutical Industries USD 2.29B 87M 2025-03
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Neurocrine Biosciences Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.